Paragon 28 Inc (FRA:7GQ)
€ 9.75 0.4 (4.28%) Market Cap: 819.46 Mil Enterprise Value: 887.25 Mil PE Ratio: 0 PB Ratio: 6.19 GF Score: 34/100

Paragon 28 Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 08:55PM GMT
Release Date Price: €12.5 (-3.10%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Thank you, everyone, for joining us this afternoon. I'm Drew Ranieri, one of the medical device analyst here at Morgan Stanley. It's my pleasure to have Paragon 28 with us this afternoon. From the company, we have CEO, Albert DaCosta, CFO Steve Deitsch. And thank you both for being here today, making the trip over from Denver. Before we get started, quick disclosure. But for disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. With that, let's kind of get into the discussion today.

Questions & Answers

Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Maybe first for Albert, we can kind of dig into your views on the market. But to start, let's talk about the F&A market at large. You've sized it before about $6 billion, maybe growing high single digits. There's more commentary from large joint companies. I know you're a little apples and oranges there, but that there could be a modest

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot